Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis

doi:10.3748/wjg.v11.i40.6322

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3406)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

375

HTML

2634

Figures (1-9)

195

Tables (1-2)

202

Sum=3406

Oct 28, 2005 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Oct 28, 2005; 11(40): 6322-6329
Published online Oct 28, 2005. doi: 10.3748/wjg.v11.i40.6322

Full Size Figure Download Figure

Figure 3 Plasma lipase activity in rats with or without CIP and pretreated with saline or pioglitazone at a dose 50 mg/kg. Mean±SE of eight rats in each experimental group. Asterisk indicates a significant change as compared to the value in rats infused with saline. Cross indicates a significant change as compared to rats with CIP alone. aP<0.05 vs CIP alone.

Citation: Konturek PC, Dembinski A, Warzecha Z, Burnat G, Ceranowicz P, Hahn EG, Dembinski M, Tomaszewska R, Konturek SJ. Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis. World J Gastroenterol 2005; 11(40): 6322-6329
URL: https://www.wjgnet.com/1007-9327/full/v11/i40/6322.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i40.6322